Error: Could not add to watchlist. X

Atrium Innovations Inc

+ Watchlist
ATB:CN
Acquired
ATB:CN was acquired by 727032Z:LN
CAD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
1.70
Market Cap (CAD)
-
Shares Outstanding (m)
31.379
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Atrium Innovations Inc. develops, manufactures, and markets products for the cosmetics, pharmaceutical, chemical, and nutrition industries. The Company focuses primarily on growing segments of the health and personal care markets. Atrium markets a broad portfolio of active ingredients, specialty chemicals, and health and nutrition finished products.
ADDRESS
1405 Parc-Technologique Blvd
Quebec, QC G1P 4P5
Canada
PHONE
1-418-652-1116
  • Peter Luther
    President/CEO
  • Paul Hannema
    Exec VP/Head:European Ops
  • Serge Yelle
    Exec VP:Strategy & Bus Dev
  • Donald S Allen
    Senior VP:Supply Chain
  • Mario Paradis
    VP/CFO
Show More